J Neuroinflammation
The *Journal of Neuroinflammation* (ISSN: 1742-2094) is a premier, peer-reviewed, open-access publication dedicated to advancing the understanding of the immune and inflammatory mechanisms underlying neurological disorders. Published by BioMed Central (part of Springer Nature), the journal provides a high-impact forum for research at the intersection of immunology, neuroscience, and clinical neurology. Its scope encompasses the full spectrum of neuroinflammatory processes, including their roles in neurodegenerative diseases such as Alzheimer's, Parkinson's, and multiple sclerosis, as well as in stroke, traumatic brain injury, spinal cord injury, and neuropsychiatric conditions. The journal also covers microbial infections of the central nervous system, autoimmune encephalitis, and the contribution of glial cells—particularly microglia and astrocytes—to neuroinflammation and neuroprotection. The journal publishes a diverse range of article types, including original research articles, comprehensive reviews, short communications, and methodological papers. It actively encourages studies employing cutting-edge technologies such as single-cell transcriptomics, advanced neuroimaging, and novel animal models. The primary target audience comprises neuroscientists, immunologists, neurologists, psychiatrists, and translational researchers seeking to bridge basic mechanistic insights with therapeutic applications. A standout feature is its fully open-access model, ensuring that all published content is freely and permanently available online, thereby maximizing global dissemination and citation. The journal holds a distinguished position in its field, as reflected by its 2026 Impact Factor of 9.5870 and its consistent ranking in the JCR Q1 quartile. This places it among the most influential and highly cited journals in both the neurosciences and immunology categories, making it a vital resource for cutting-edge research on the immune system’s role in brain health and disease.